Pages that link to "Q34022920"
Jump to navigation
Jump to search
The following pages link to Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models (Q34022920):
Displaying 50 items.
- Ketogenic Diets: An Update for Child Neurologists (Q22299266) (← links)
- Chronic ingestion of 2-deoxy-D-glucose induces cardiac vacuolization and increases mortality in rats (Q24634601) (← links)
- Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI) (Q26825591) (← links)
- Mitochondrial involvement and oxidative stress in temporal lobe epilepsy (Q26865259) (← links)
- Harnessing the power of metabolism for seizure prevention: focus on dietary treatments (Q26991869) (← links)
- Metabolic Therapy for Temporal Lobe Epilepsy in a Dish: Investigating Mechanisms of Ketogenic Diet using Electrophysiological Recordings in Hippocampal Slices (Q28071552) (← links)
- Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet (Q28272457) (← links)
- BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures (Q30514237) (← links)
- Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels (Q33857877) (← links)
- Non-ketogenic combination of nutritional strategies provides robust protection against seizures (Q33905611) (← links)
- Glycolysis in energy metabolism during seizures (Q33937088) (← links)
- Ketogenic diets and pain (Q34014157) (← links)
- Potent anti-seizure effects of D-leucine (Q34479759) (← links)
- Ketogenic diets: from cancer to mitochondrial diseases and beyond. (Q34509699) (← links)
- Ketogenic diets: evidence for short- and long-term efficacy (Q34971377) (← links)
- Purines and the Anti-Epileptic Actions of Ketogenic Diets (Q35513799) (← links)
- Mitochondrial respiration deficits driven by reactive oxygen species in experimental temporal lobe epilepsy (Q35736503) (← links)
- The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy (Q35852049) (← links)
- Ketogenic diets, mitochondria, and neurological diseases (Q36196765) (← links)
- Dietary therapies for epilepsy and other neurological disorders: highlights of the 3rd international symposium (Q36804600) (← links)
- 2-Deoxy-d-Glucose (2-DG)-Induced Cardiac Toxicity in Rat: NT-proBNP and BNP as Potential Early Cardiac Safety Biomarkers (Q36892819) (← links)
- Finding a better drug for epilepsy: antiepileptogenesis targets. (Q37232240) (← links)
- Alterations of hippocampal glucose metabolism by even versus uneven medium chain triglycerides. (Q37459904) (← links)
- New and investigational antiepileptic drugs (Q37638688) (← links)
- Golgi apparatus dis- and reorganizations studied with the aid of 2-deoxy-D-glucose and visualized by 3D-electron tomography (Q37712748) (← links)
- Triheptanoin--a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment? (Q37920144) (← links)
- Neuroprotection in metabolism-based therapy (Q37923014) (← links)
- Ketogenic diets: new advances for metabolism-based therapies (Q37982950) (← links)
- Mechanisms of physiological and epileptic HFO generation. (Q37993959) (← links)
- The Epilepsy Foundation's 4th Biennial Epilepsy Pipeline Update Conference (Q38448072) (← links)
- The ketogenic diet in pharmacoresistant childhood epilepsy (Q38494270) (← links)
- How does the ketogenic diet work? Four potential mechanisms (Q38582924) (← links)
- The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction (Q38809233) (← links)
- Glycolytic inhibition by 2-deoxy-d-glucose abolishes both neuronal and network bursts in an in vitro seizure model (Q38839414) (← links)
- Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII). (Q39006241) (← links)
- Alternative Fuels in Epilepsy and Amyotrophic Lateral Sclerosis. (Q39014987) (← links)
- Food for thought: Impact of metabolism on neuronal excitability. (Q39163919) (← links)
- The Epigenetics of Epilepsy and Its Progression (Q39281184) (← links)
- Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment. (Q41984278) (← links)
- Glycolysis Inhibition: The Gift of GAB(A) (Q42084996) (← links)
- Posttraumatic Epilepsy: What's Contusion Got to Do With It? (Q42183961) (← links)
- Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models (Q42409348) (← links)
- Effect of low Mg2+ and bicuculline on cell survival in hippocampal slice cultures (Q42860444) (← links)
- Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE. (Q47637754) (← links)
- Enhancement of phrenic long-term facilitation following repetitive acute intermittent hypoxia is blocked by the glycolytic inhibitor 2-deoxyglucose (Q47747292) (← links)
- BAD and KATP channels regulate neuron excitability and epileptiform activity. (Q47840670) (← links)
- Chronic inhibition of brain glycolysis initiates epileptogenesis (Q48048374) (← links)
- Epilepsy and astrocyte energy metabolism. (Q48051352) (← links)
- A resurging boom in new drugs for epilepsy and brain disorders. (Q48093388) (← links)
- The antiepileptic effect of the glycolytic inhibitor 2-deoxy-D-glucose is mediated by upregulation of K(ATP) channel subunits Kir6.1 and Kir6.2. (Q48132392) (← links)